secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2023-02-15T23:59:59+00:00
Accession:  0001906324-23-000008
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho reports Q4 2022 revenue $866.5M, GAAP EPS $0.45; supplemental adjusted EPS $1.76 down 66% YoY
--------------------------------------------------------------------------------

- Q4 GAAP EPS $0.45 vs $6.85 prior year; supplemental adjusted EPS $1.76, down 66% YoY.
- Revenue $866.5M, up 36% as reported; supplemental combined revenue down 23% constant currency ex-COVID.
- Full year 2022 GAAP EPS $9.56; supplemental adjusted EPS $13.80, up 1%.
- Ex-COVID growth driven by Point of Care and Molecular Diagnostics; Labs weak due to China lockdowns and supply chain.
- Integration cost synergies ahead of plan; 2023 guidance to be provided on conference call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632423000008/0001906324-23-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632423000008/qdel-20230215.htm
  HTML page:      https://secwatch.observer/filing/0001906324-23-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer